Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rep. Honda Reintroduces Bill To Create FDA Office Of Wireless Health

This article was originally published in The Gray Sheet

Executive Summary

Reintroduced bill from Rep. Mike Honda targets regulatory uncertainty, lack of capital in health information technology market.

You may also be interested in...



FDA Role, Safety Oversight Addressed In Health IT Framework Comments

Debate over the appropriate system for regulating health IT tools continued in written comments recently submitted to HHS.

Workgroup Unveils Preliminary Health IT Regulation Proposals

An HHS-sponsored workgroup issued its initial recommendations for a health IT regulatory framework, featuring risk-based oversight, adverse event reporting and better agency coordination.

Digital Health In Brief

Rep. Honda to introduce refined Office of Wireless Health bill; survey shows disappointing meaningful use uptake, more digital briefs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel